United States Healthcare Equipment & Supplies

Shoulder Innovations Inc (SI)

Track

Track

Shoulder Innovations Inc. experienced twelve insider trading transactions over the past ninety days, totaling approximately 9.9 million dollars in sales. Gilde Healthcare Holding B.V. and Matthew Ahearn executed these divestments. This activity follows the company's recent results financiers, occurring amidst a thirty-four percent stock price increase.
Ticker: SI Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Shoulder Innovations Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Ahearn Matthew Fraser Chief Operating Officer Executive Director
Transaction date
Planned sale
Price
412.66
Quantity 91,991 -13.5%
Value US$4,899,633
Ahearn Matthew Fraser Chief Operating Officer Executive Director
Transaction date
Planned sale
Price
114.25
Quantity 40,536 -32.1%
Value US$3,221,108
Ahearn Matthew Fraser Chief Operating Officer Executive Director
Transaction date
Planned sale
Price
436.44
Quantity 1,120 -32.4%
Value US$2,180,489
MATTHEW AHEARN Director; Officer Executive Director
Transaction date
Proposed sale
Price
20.73
Quantity 1,000
Value US$100,000
Ahearn Matthew Fraser Chief Operating Officer Executive Director
Transaction date
Planned sale
Price
19.26
Quantity 2,500 -0.9%
Value US$48,148
Ahearn Matthew Fraser Chief Operating Officer Executive Director
Transaction date
Planned sale
Price
18.20
Quantity 1,644 -0.6%
Value US$29,922
Ahearn Matthew Fraser Chief Operating Officer Executive Director
Transaction date
Planned sale
Price
18.68
Quantity 15,856 -5.5%
Value US$296,185
MATTHEW AHEARN Director; Officer Executive Director
Transaction date
Proposed sale
Price
18.76
Quantity 20,000
Value US$375,200
3.7
Points Jeffrey S. Chief Financial Officer Officer
Transaction date
Purchase
Price
15.00
Quantity 2,000 +2.9%
Value US$30,000
2.5
Buchholz Richard Non-Executive Director
Transaction date
Purchase
Price
14.84
Quantity 1,000 +7.9%
Value US$14,840
2.1
Ball Robert Joseph CEO & Executive Chairman Executive Director
Transaction date
Purchase
Price
15.18
Quantity 2,200 +0.8%
Value US$33,392
2.1
Ball Robert Joseph CEO & Executive Chairman Executive Director
Transaction date
Purchase
Price
14.89
Quantity 3,900 +3.4%
Value US$58,075
3.7
Points Jeffrey S. Chief Financial Officer Officer
Transaction date
Purchase
Price
14.98
Quantity 1,005 +1.9%
Value US$15,055
2.1
Ball Robert Joseph CEO & Executive Chairman Executive Director
Transaction date
Purchase
Price
14.83
Quantity 3,300 +3.0%
Value US$48,934
3.7
Points Jeffrey S. Chief Financial Officer Officer
Transaction date
Purchase
Price
14.65
Quantity 995 +1.9%
Value US$14,577
3.7
Points Jeffrey S. CHIEF FINANCIAL OFFICER Officer
Transaction date
Purchase
Price
15.67
Quantity 1,600 +3.1%
Value US$25,072
2.1
Ball Robert Joseph CEO & EXECUTIVE CHAIRMAN Executive Director
Transaction date
Purchase
Price
15.49
Quantity 6,000 +5.7%
Value US$92,945
2.1
Ball Robert Joseph CEO & EXECUTIVE CHAIRMAN Executive Director
Transaction date
Purchase
Price
14.90
Quantity 2,000 +1.9%
Value US$29,810
3.7
Points Jeffrey S. CHIEF FINANCIAL OFFICER Officer
Transaction date
Purchase
Price
15.00
Quantity 50 +inf%
Value US$750
1.6
Carusi Michael A Non-Executive Director
Transaction date
Purchase
Price
15.00
Quantity 266,666 +16.5%
Value US$3,999,990
1.6
Pardo Geoffrey B Non-Executive Director Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 100,000 +4.4%
Value US$1,500,000
2.5
Buchholz Richard Non-Executive Director
Transaction date
Purchase
Price
15.00
Quantity 5,000 +65.2%
Value US$75,000
2.3
Tansey Casey M Non-Executive Director Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 40,000 +521.8%
Value US$600,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-18 2026-08-18 PlS Planned sale
Ahearn Matthew Fraser

Chief Operating Officer

Executive Director
91,991 -13.5%
412.66
US$4,899,633 		91,991 -13.5% 412.66 US$4,899,633
2026-08-18 2026-08-18 PlS Planned sale
Ahearn Matthew Fraser

Chief Operating Officer

Executive Director
40,536 -32.1%
114.25
US$3,221,108 		40,536 -32.1% 114.25 US$3,221,108
2026-08-18 2026-08-17 PlS Planned sale
Ahearn Matthew Fraser

Chief Operating Officer

Executive Director
1,120 -32.4%
436.44
US$2,180,489 		1,120 -32.4% 436.44 US$2,180,489
2026-08-17 2026-08-17 PrS Proposed sale
MATTHEW AHEARN

Director; Officer

Executive Director
1,000
20.73
US$100,000 		1,000 20.73 US$100,000
2026-08-07 2026-08-06 S Sale
2.6
Gilde Healthcare Holding B.V.
Large shareholder
1,000 -0.1%
22.60
US$100,000 		1,000 -0.1% 22.60 US$100,000
2026-08-07 2026-08-05 S Sale
2.6
Gilde Healthcare Holding B.V.
Large shareholder
1,000 -0.3%
22.64
US$100,000 		1,000 -0.3% 22.64 US$100,000
2026-08-05 2026-08-04 S Sale
2.6
Gilde Healthcare Holding B.V.
Large shareholder
1,000 -4.3%
22.77
US$100,000 		1,000 -4.3% 22.77 US$100,000
2026-08-05 2026-08-03 S Sale
2.6
Gilde Healthcare Holding B.V.
Large shareholder
1,000 -0.5%
22.71
US$100,000 		1,000 -0.5% 22.71 US$100,000
2026-08-03 2026-07-31 S Sale
2.6
Gilde Healthcare Holding B.V.
Large shareholder
1,000 -0.9%
22.73
US$100,000 		1,000 -0.9% 22.73 US$100,000
2026-08-03 2026-07-30 S Sale
2.6
Gilde Healthcare Holding B.V.
Large shareholder
1,000 -1.2%
23.36
US$100,000 		1,000 -1.2% 23.36 US$100,000
2026-07-29 2026-07-29 PrS Proposed sale
2.6
Gilde Healthcare Holding B.V.; Cooperatieve Gilde Healthcare V U.A.

10% Stockholder

Large shareholder
1,000
24.25
US$100,000 		1,000 24.25 US$100,000
2026-06-16 2026-06-15 PlS Planned sale
Ahearn Matthew Fraser

Chief Operating Officer

Executive Director
2,500 -0.9%
19.26
US$48,148 		2,500 -0.9% 19.26 US$48,148
2026-06-16 2026-06-15 PlS Planned sale
Ahearn Matthew Fraser

Chief Operating Officer

Executive Director
1,644 -0.6%
18.20
US$29,922 		1,644 -0.6% 18.20 US$29,922
2026-06-16 2026-06-12 PlS Planned sale
Ahearn Matthew Fraser

Chief Operating Officer

Executive Director
15,856 -5.5%
18.68
US$296,185 		15,856 -5.5% 18.68 US$296,185
2026-06-12 2026-06-12 PrS Proposed sale
MATTHEW AHEARN

Director; Officer

Executive Director
20,000
18.76
US$375,200 		20,000 18.76 US$375,200
2026-03-17 2026-03-13 B Purchase
3.7
Points Jeffrey S.

Chief Financial Officer

Officer
2,000 +2.9%
15.00
US$30,000 		2,000 +2.9% 15.00 US$30,000
2026-03-17 2026-03-13 B Purchase
2.5
Buchholz Richard
Non-Executive Director
1,000 +7.9%
14.84
US$14,840 		1,000 +7.9% 14.84 US$14,840
2026-03-17 2026-03-13 B Purchase
2.1
Ball Robert Joseph

CEO & Executive Chairman

Executive Director
2,200 +0.8%
15.18
US$33,392 		2,200 +0.8% 15.18 US$33,392
2025-12-15 2025-12-12 B Purchase
2.1
Ball Robert Joseph

CEO & Executive Chairman

Executive Director
3,900 +3.4%
14.89
US$58,075 		3,900 +3.4% 14.89 US$58,075
2025-12-15 2025-12-12 B Purchase
3.7
Points Jeffrey S.

Chief Financial Officer

Officer
1,005 +1.9%
14.98
US$15,055 		1,005 +1.9% 14.98 US$15,055
2025-12-15 2025-12-11 B Purchase
2.1
Ball Robert Joseph

CEO & Executive Chairman

Executive Director
3,300 +3.0%
14.83
US$48,934 		3,300 +3.0% 14.83 US$48,934
2025-12-15 2025-12-11 B Purchase
3.7
Points Jeffrey S.

Chief Financial Officer

Officer
995 +1.9%
14.65
US$14,577 		995 +1.9% 14.65 US$14,577
2025-09-15 2025-09-12 B Purchase
3.7
Points Jeffrey S.

CHIEF FINANCIAL OFFICER

Officer
1,600 +3.1%
15.67
US$25,072 		1,600 +3.1% 15.67 US$25,072
2025-09-15 2025-09-12 B Purchase
2.1
Ball Robert Joseph

CEO & EXECUTIVE CHAIRMAN

Executive Director
6,000 +5.7%
15.49
US$92,945 		6,000 +5.7% 15.49 US$92,945
2025-09-15 2025-09-11 B Purchase
2.1
Ball Robert Joseph

CEO & EXECUTIVE CHAIRMAN

Executive Director
2,000 +1.9%
14.90
US$29,810 		2,000 +1.9% 14.90 US$29,810
2025-08-05 2025-08-01 B Purchase
2.6
Gilde Healthcare Holding B.V.
Large shareholder
100,000 +4.4%
15.00
US$1,500,000 		100,000 +4.4% 15.00 US$1,500,000
2025-08-05 2025-08-01 B Purchase
3.7
Points Jeffrey S.

CHIEF FINANCIAL OFFICER

Officer
50 +inf%
15.00
US$750 		50 +inf% 15.00 US$750
2025-08-05 2025-08-01 B Purchase
1.6
Carusi Michael A
Non-Executive Director
266,666 +16.5%
15.00
US$3,999,990 		266,666 +16.5% 15.00 US$3,999,990
2025-08-05 2025-08-01 B Purchase
1.6
LSV Associates II, LLC
266,666 +16.5%
15.00
US$3,999,990 		266,666 +16.5% 15.00 US$3,999,990
2025-08-05 2025-08-01 B Purchase
1.6
Pardo Geoffrey B
Non-Executive Director Large shareholder
100,000 +4.4%
15.00
US$1,500,000 		100,000 +4.4% 15.00 US$1,500,000
2025-08-05 2025-08-01 B Purchase
2.5
Buchholz Richard
Non-Executive Director
5,000 +65.2%
15.00
US$75,000 		5,000 +65.2% 15.00 US$75,000
2025-08-05 2025-08-01 B Purchase
2.3
Tansey Casey M
Non-Executive Director Large shareholder
40,000 +521.8%
15.00
US$600,000 		40,000 +521.8% 15.00 US$600,000
Explore more

More insider trading research around Shoulder Innovations Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America